Neumora Therapeutics, Inc. Common Stock (NMRA) Ownership

$2.48

north_east
$0.31 (14.29%)
Day's range
$2.19
Day's range
$2.59

Neumora Therapeutics, Inc. Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 7.11 M $75.33 M   14.87% 4.46%
SOFTBANK GROUP CORP. 02/14/2025 6.54 M $69.34 M   -13.33% 4.10%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/14/2025 5.00 M $53.03 M   -4.31% 3.14%
MIC CAPITAL MANAGEMENT UK LLP 02/14/2025 4.46 M $47.28 M   0.00% 2.80%
SIREN, L.L.C. 02/14/2025 4.40 M $46.60 M   68.65% 2.76%
DEEP TRACK CAPITAL, LP 02/14/2025 4.00 M $42.40 M   604.94% 2.51%
CAPITAL INTERNATIONAL INVESTORS 02/13/2025 3.70 M $39.22 M   692.06% 2.32%
WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST 01/13/2025 3.31 M $35.08 M   0.00% 2.08%
ICONIQ CAPITAL, LLC 02/14/2025 2.56 M $27.13 M   -24.70% 1.61%
LUNATE HOLDING RSC LTD 02/14/2025 2.12 M $22.52 M   100.00% 1.33%
ECOR1 CAPITAL, LLC 02/14/2025 2.07 M $21.96 M   0.00% 1.30%
JOHNSON & JOHNSON 02/13/2025 1.85 M $19.60 M   0.00% 1.16%
CAPTION MANAGEMENT, LLC 02/14/2025 1.52 M $16.10 M   653.17% 0.95%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 1.50 M $15.90 M   100.00% 0.94%
DEEP TRACK CAPITAL, LP 02/14/2025 1.19 M $12.61 M   559.17% 0.75%
BAKER BROS. ADVISORS LP 02/14/2025 1.03 M $10.97 M   0.00% 0.65%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 955,106 $10.12 M   15.34% 0.60%
IKARIAN CAPITAL, LLC 02/14/2025 900,000 $9.54 M   125.00% 0.56%
ORBIMED ADVISORS LLC 02/14/2025 804,996 $8.53 M   -46.33% 0.51%
SIO CAPITAL MANAGEMENT, LLC 02/14/2025 636,300 $6.74 M   100.00% 0.40%
CALLAN CAPITAL, LLC 02/03/2025 636,194 $6.74 M   -3.78% 0.40%
CAPTION MANAGEMENT, LLC 02/14/2025 633,300 $6.71 M   100.00% 0.40%
LMR PARTNERS LLP 02/14/2025 616,400 $6.53 M   507.29% 0.39%
CANDRIAM S.C.A. 02/07/2025 571,027 $6.05 M   -15.56% 0.36%
SCHONFELD STRATEGIC ADVISORS LLC 02/14/2025 521,013 $5.52 M   273.92% 0.33%
AFFINITY ASSET ADVISORS, LLC 02/13/2025 475,000 $5.04 M   100.00% 0.30%
STEMPOINT CAPITAL LP 02/14/2025 428,137 $4.54 M   100.00% 0.27%
IKARIAN CAPITAL, LLC 02/14/2025 350,000 $3.71 M   -12.50% 0.22%
WOODLINE PARTNERS LP 02/14/2025 310,454 $3.29 M   0.94% 0.19%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 289,300 $3.07 M   147.27% 0.18%
SOROS CAPITAL MANAGEMENT LLC 02/14/2025 279,333 $2.96 M   -45.11% 0.18%
WEXFORD CAPITAL LP 02/14/2025 252,122 $2.67 M   15.72% 0.16%
CERITY PARTNERS LLC 02/13/2025 243,908 $2.59 M   0.42% 0.15%
ADDIS & HILL, INC 01/31/2025 163,386 $1.73 M   -45.54% 0.10%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2025 150,936 $1.60 M   -2.00% 0.09%
ENSIGN PEAK ADVISORS, INC 02/14/2025 150,000 $1.59 M   0.00% 0.09%
AVIDITY PARTNERS MANAGEMENT LP 02/14/2025 150,000 $1.59 M   100.00% 0.09%
CUTTER CAPITAL MANAGEMENT, LP 02/14/2025 150,000 $1.59 M   100.00% 0.09%
ALPS ADVISORS INC 02/13/2025 130,644 $1.38 M   10.56% 0.08%
CAPTION MANAGEMENT, LLC 02/14/2025 104,776 $1.11 M   100.00% 0.07%
WINDMILL HILL ASSET MANAGEMENT LTD 02/26/2025 104,373 $1.11 M   299.58% 0.07%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 101,000 $1.07 M   -13.68% 0.06%
02/14/2025 81,200 $860,720   100.00% 0.05%
BREVAN HOWARD CAPITAL MANAGEMENT LP 02/14/2025 80,559 $853,925   100.00% 0.05%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 68,608 $727,245   100.00% 0.04%
TD ASSET MANAGEMENT INC 02/11/2025 68,418 $725,231   -54.51% 0.04%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/14/2025 66,669 $706,691   100.00% 0.04%
HAP TRADING, LLC 02/13/2025 53,800 $17,155   100.00% 0.03%
NUMERAI GP LLC 02/14/2025 51,696 $547,978   46.70% 0.03%
LMR PARTNERS LLP 02/14/2025 50,000 $530,000   100.00% 0.03%

Neumora Therapeutics, Inc. Common Stock institutional Ownership - FAQ's

During the previous two years, 85 institutional investors and hedge funds held shares of Neumora Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 7.11 M

SOFTBANK GROUP CORP.: 6.54 M

T. Rowe Price Investment Management, Inc.: 5 M

MIC Capital Management UK LLP: 4.46 M

Siren, L.L.C.: 4.4 M

Deep Track Capital, LP: 4 M

50.43% of Neumora Therapeutics, Inc. Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 55.61 M shares in the last 24 months. This purchase volume represents approximately $137.92 M in transactions.